Daphnoretin, a biologically active principle isolated from Wikstroemia indica C.A. Mey., caused platelet aggregation in washed rabbit platelets, platelet-rich plasma and whole blood. The aggregation of and ATP release from platelets induced by daphnoretin were similar to phorbol ester-and diacylglycerol-induced aggregation and release. The EC50 values of daphnoretin-, phorbol 12,13-dibutyrate (PDBu)-and I-oleoyl-2-acetylglycerol (OAG)-induced platelet aggregation in washed rabbit platelets were 17.2 + 2.8 ,uM, 20.6 + 2.1 nM and 38.6 + 1.7 1sM respectively. Platelet aggregation induced by daphnoretin and PDBu was not inhibited by indomethacin, BN52021 or sodium nitroprusside. ADP-scavenging systems, apyrase and phosphocreatine/creatine kinase, showed weak inhibition of the aggregation, and EGTA, triflavin, verapamil and prostaglandin E1 markedly inhibited the aggregation. Staurosporine, a potent protein kinase C inhibitor, suppressed daphnoretin-, PDBu-and OAG-induced aggregation and ATP release in a concentration-
INTRODUCTION
Protein kinase C (PKC) is a Ca2+-and phospholipid-dependent protein serine-and/or threonine-specific kinase [1] . This enzyme is activated directly by diacylglycerol produced by signal-induced inositol phospholipid turnover [2] and tumour promoters such as 12-O-tetradecanoylphorbol 13-acetate (TPA) and phorbol 12,13-dibutyrate (PDBu) [3, 4] . When cells are stimulated, an apparent translocation of PKC from the soluble fraction to the membrane occurs in a Ca2l-dependent manner [5] . PKC has also been demonstrated to be the intracellular receptor for the tumourpromoting phorbol esters which activate the enzyme by interaction at the sn-1,2-diacylglycerol site [6] [7] [8] . PKC plays a central role in a wide variety of cell types. In platelets, it is supposed to be involved in the cellular activation process, which is initiated by the phosphorylation of specific proteins and results in granule release and aggregation [9] [10] [11] .
Wikstroemia indica C.A. Mey. is a plant belonging to the Thymelaceae. The root of this plant is used as a folk remedy for arthritis, tuberculosis, syphilis and pertussis. The bicoumarin, daphnoretin (7-hydroxy-6-methoxy-3,7'-dicoumaryl ether), had been isolated from Wikstroemia indica C.A. Mey. [12] as well as Daphne mezereum L. and Daphne cannabina Wall [13] . Recently, we found that it induced aggregation of washed rabbit platelets in a manner similar to 1,2-diacylglycerols and phorbol esters. In this paper, we investigated the biological activity governed by daphnoretin in rabbit platelets. We mechanism(s) of this activity and compared it with that of PDBu and l-oleoyl-2-acetylglycerol (OAG). EXPERIMENTAL Materials Daphnoretin ( Figure 1 ) was isolated from the plant, Wikstroemia indica C.A. Mey., as described previously [12] . Collagen (type I, bovine Achilles tendon), from Sigma Chemical Co., was homogenized in 25 mM acetic acid and stored (1 mg/ml) at -70 'C. Bovine thrombin obtained from Parke Davis Co. was dissolved in glycerol (50 %, v/v) for a stock solution of 100 NIH units/ml. Platelet-activating factor (PAF; l-O-alkyl-2-acetyl-snglycero-3-phosphocholine) purchased from At the end of the experiment the cells were treated with 0.1 % Triton X-100 followed by the addition of 10 mM EGTA to obtain the maximal and minimal fluorescence respectively.
[Ca21]
was calculated as described for Fura-2 using a Ca2+-dye dissociation constant of 224 nM [20] .
Labelling of membrane phospholipids and measurement of the production of [3H]Inositol phosphate
The method employed was modified from those of Huang and Detwiler [21] and Neylon and Summers [22] . EDTA/PRP was centrifuged at 500 g for 10 min. Platelet pellets were then suspended in 1 ml of Ca2+-free and BSA-free Tyrode's solution containing myo-[2-3H]inositol (75 1tCi/ml) and EDTA (1 mM). After incubation for 2 h at 37°C, the platelets were collected by centrifugation (1500 g, 4 min) and suspended in Tyrode's solution (3 x 108 platelets/ml). Phosphoinositide breakdown was enabled by addition of aggregation inducers to the platelet suspension (1 ml) in a 3.5 ml cuvette with a stirring bar driven at 1200 rev/min. Incubation was continued for either 6 or 20 min at 37 'C. An equal volume of 10 % (w/v) trichloroacetic acid was then added to stop the reaction. After centrifugation at 1000 g for 10 min, 1 ml of supernatant was aspirated and trichloroacetic acid removed by washing with diethyl ether. The aqueous phase containing inositol phosphates was adjusted to pH 7-8, diluted to 4 ml with distilled water, and applied to a Dowex 1 ionexchange column for separation of inositol phosphates as described by Neylon and Summers [22] Effect of some pharmacological agents on the platelet aggregation induced by daphnoretin, PDBu and OAG In the presence of indomethacin (10 ,uM) and BN52021 (20 ,uM) , arachidonic acid (100 ,uM)-and PAF (3.6 nM)-induced platelet aggregations were completely inhibited. However, indomethacin and BN52021 did not inhibit daphnoretin (50 ,uM)--and PDBu (100 nM)-induced aggregation in washed rabbit platelets ( Table  2 ). Apyrase and phosphocreatine/creatine kinase were used as an ADP-scavenging system to study the effect of ADP released from platelets on the aggregation induced by daphnoretin and PDBu. Exogenous addition of ADP (20 ,uM) could not induce platelet aggregation in the presence of apyrase (1 unit/ml) or phosphocreatine/creatine kinase (5 mM/8 units per ml). Both daphnoretin-and PDBu-induced aggregations were partially suppressed by apyrase (1 unit/ml) and phosphocreatine/creatine kinase (5 mM/8 units per ml). When the concentrations of apyrase and phosphocreatine/creatine kinase were doubled, they did not cause more pronounced inhibition in daphnoretin-and PDBu-induced aggregation (Table 2) . Among the pharmacological agents tested, EGTA (3 mM), verapamil (50 ,uM), triflavin (20 ,ug/ml) and PGE1 (1 and 10 ,uM) all inhibited daphnoretinand PDBu-induced aggregation markedly but incompletely (Table 2 ). Nitroprusside (10 #M) did not inhibit daphnoretinand PBDu-induced platelet aggregation (Table 2) . Staurosporine, a potent PKC inhibitor [25] , inhibited daphnoretin-, PDBuand OAG-induced aggregation completely in a concentrationdependent manner with IC50 37.7 + 8.3, 52.2 + 6.3 and 42.8 + 8.9 nM respectively (Figure 3 ).
Thromboxane B2 formation in platelets treated with daphnoretin
The thromboxane B2 level of resting platelets (3 x 108/ml) was 1.6 + 0.4 ng/ml. Arachidonic acid (100 ,uM), collagen (10 jug/ml) and thrombin (0.1 unit/ml) markedly increased the thromboxane B2 level after stimulation of platelets for 6 min. PAF (3.6 nM) also caused a slight increase in platelet thomboxane B2 level. At the concentration used for inducing maximal aggregation of platelets, daphnoretin (50 uM) did not cause significant thromboxane B2 formation when compared with the basal level at resting state (Table 3 (Figure 4) . PDBu (100 nM) also platelets ( Figure 2 ). Compared with thrombin and collagen, 
DISCUSSION
Platelet aggregation requires exposure of fibrinogen receptors to which fibrinogen binds in the presence of bivalent cations [26] . Chelation of extracellular Ca2+ inhibits the binding of fibrinogen to its receptor [27] . EGTA is a Ca2+ chelator which inhibits platelet aggregation by reducing extracellular free Ca2+ and thus prevents fibrinogen binding to its receptor. Triflavin, an RGDcontaining peptide isolated from Trimeresurusflavoviridis snake venom, inhibits platelet aggregation by interfering with fibrinogen binding to its receptor associated with the glycoprotein Ib-Illa complex [15] . Cyclic AMP is one of the most potent platelet inhibitors. Elevated cyclic AMP inhibits most platelet responses including aggregation. PGE1 inhibits platelet aggregation by elevating the platelet cyclic AMP level [28] . In our experiments, Daphnoretin and PDBu increased the light transmittance of washed rabbit platelets. The increase in light transmittance was markedly blocked by EGTA, triflavin and PGE1. Lactate dehydrogenase activity in the supernatant of platelet suspension challenged with daphnoretin was not increased (results not shown). All these data indicate that daphnoretin induced aggregation of rabbit platelets but not cell lysis or agglutination. Like PDBu and OAG, but not other platelet stimuli, daphnoretin induced slow platelet responses ( Figure 2 and Table 1) . Daphnoretin-and PDBu-induced platelet aggregation also possessed similar susceptibility to some pharmacological agents. Thromboxane A2, ADP and PAF are three important mediators usually formed and/or liberated from platelets by aggregation inducers such as thrombin and collagen, thereby amplifying platelet responses. Indomethacin, which inhibits the platelet cyclo-oxygenase and prevents the formation of thromboxane A2, did not inhibit platelet aggregation caused by daphnoretin and PDBu. Daphnoretin also did not induce thromboxane B2 formation in platelets. These data indicate that daphnoretin-and PDBu-induced platelet aggregation was independent of thromboxane formation. These results are also consistent with previous reports that diacylglycerols and phorbol esters do not induce arachidonate release and formation of arachidonate metabolites [29] [30] [31] [32] . BN52021, a specific PAF antagonist, did not affect daphnoretin-and PDBu-induced platelet aggregation. This result implies that PAF also does not mediate daphnoretin-and PDBu-induced rabbit platelet aggregation. However, apyrase (1 unit/ml) and phosphocreatine/creatine kinase (5 mM/8 units per ml), two ADP-scavenging enzyme systems, slightly suppressed daphnoretin-and PDBu-induced platelet aggregation. Doubling the concentration of apyrase or phosphocreatine/ creatine kinase did not cause additional inhibition. Thus released ADP plays only a minor role in mediating daphnoretin-and PDBu-induced aggregation of rabbit platelets. It has been reported that verapamil non-specifically inhibited PKC activity by competition with phospholipid [33] . Staurosporine is the most potent inhibitor which binds near the catalytic site of PKC [25] .
PDBu-and OAG-induced platelet aggregation and ATP release in a concentration-dependent manner (Figure 3 ). These data strongly suggest that daphnoretin, like PDBu and OAG, may induce platelet responses by stimulating PKC activity.
In resting platelets, PKC is present in an inactive and soluble form in the cytosol. This enzyme is activated directly by diacylglycerol produced by signal-induced inositol phospholipid turnover [2] and phorbol esters such as TPA and PDBu [3, 4] .
After that, PKC shifts from the cytosol to the membrane [34] . As phosphoinositide breakdown is observed in platelets activated by many agonists, this process may be a primary event in agonistinduced activation [35, 36] . Diacylglycerols and phorbol esters do not induce inositol phospholipid hydrolysis in platelets [29] [30] [31] [32] . Diacylglycerols All the data mentioned above strongly suggest that daphnoretin directly activated platelet PKC. It is well known now that tumour-promoting phorbol esters, such as PDBu and TPA, have a diacylglycerol-like structure. They bind to PKC and activate it [3] . PKC and phorbol ester receptors seem to be identical [6, 40] . One molecule of phorbol ester binds to one molecule of PKC. Specific binding of phorbol esters to intact platelets may therefore reflect the presence of PKC in the plasma membrane [39, 41] [25] . Daphnoretin inhibited the specific [3H]PDBu binding to intact rabbit platelets in a concentration-dependent manner (Table 4 ). In addition, PKC from the platelet cytosol was activated by either daphnoretin or PDBu in a concentrationdependent manner. These results suggest that daphnoretin and PDBu bind to the same site of PKC and activate the enzyme directly.
Our results strongly suggest that daphnoretin is a rabbit platelet PKC activator. Further investigation of its tumourpromoting activity is warranted.
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